Annual Results Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is -15.94% vs 41.68% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is -32.47% vs 36.44% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 97.56% vs 41.38% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
Compare Annual Results Of Jagsonpal Pharma With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
208.70
8,558.51
-8,349.81
-97.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
208.70
8,558.51
-8,349.81
-97.56%
Raw Material Cost
22.10
859.11
-837.01
-97.43%
Purchase of Finished goods
53.98
1,825.86
-1,771.88
-97.04%
(Increase) / Decrease In Stocks
3.90
-60.74
64.64
106.42%
Employee Cost
61.80
1,890.84
-1,829.04
-96.73%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
43.86
1,859.00
-1,815.14
-97.64%
Total Expenditure (Excl Depreciation)
185.64
6,374.07
-6,188.43
-97.09%
Operating Profit (PBDIT) excl Other Income
23.06
2,184.44
-2,161.38
-98.94%
Other Income
9.28
266.64
-257.36
-96.52%
Operating Profit (PBDIT)
32.34
2,451.08
-2,418.74
-98.68%
Interest
0.81
14.57
-13.76
-94.44%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
31.53
2,436.51
-2,404.98
-98.71%
Depreciation
1.66
317.46
-315.80
-99.48%
Profit Before Tax
29.87
2,119.05
-2,089.18
-98.59%
Tax
7.41
399.17
-391.76
-98.14%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
22.46
1,719.88
-1,697.42
-98.69%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
22.46
1,823.41
-1,800.95
-98.77%
Equity Capital
13.22
40.06
-26.84
-67.00%
Face Value
5.00
1.00
0.00
Reserves
174.18
9,583.75
-9,409.57
-98.18%
Earnings per share (EPS)
3.40
45.52
-42.12
-92.53%
Diluted Earnings per share
8.46
45.45
-36.99
-81.39%
Operating Profit Margin (Excl OI)
11.05%
25.52%
0.00
-14.47%
Gross Profit Margin
15.11%
28.47%
0.00
-13.36%
PAT Margin
10.76%
20.10%
0.00
-9.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 208.70 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -11.83% vs 8.79% in Mar 2023
Annual - Standalone Net Profit
Standalone Net Profit 22.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -15.94% vs 41.68% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.06 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -32.47% vs 36.44% in Mar 2023
Annual - Interest
Interest 0.81 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 97.56% vs 41.38% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.05%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
